Completed NA INTERVENTIONAL 4-arm NCT02268539

Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in Paroxysmal Atrial Fibrillation

Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in the Treatment of Paroxysmal Atrial Fibrillation - A Pilot Study

Sponsor: Anglia Ruskin University

Conditions Paroxysmal Atrial Fibrillation

Interventions ablation

Updated 6 times since 2017 Last updated: Dec 21, 2020 Started: Feb 1, 2014 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02268539, this NA trial focuses on Paroxysmal Atrial Fibrillation and remains completed. Sponsored by Anglia Ruskin University, it has been updated 6 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2018 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting NA

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anglia Ruskin University
Mid and South Essex NHS Foundation Trust

Data source: Mid and South Essex NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basildon, United Kingdom